Michigan’s marijuana vaping products may not all be derived directly from the cannabis plant. Instead, up to 20% of these products are likely the result of a synthetic conversion from CBD to THC, posing potential risks unknown to consumers.
Synthetic THC: A Cost-effective but Risky Alternative
This alternative method involves converting CBD, a non-psychoactive compound found in hemp, into THC, the primary psychoactive component in cannabis. This process is utilized by some producers to cut costs, but it may introduce unstudied contaminants and byproducts into the vaping products.
Health Risks and Legal Implications
While the conversion process itself remains legal as long as it passes state safety tests, health experts are concerned about the potential for serious lung issues or other long-term health effects. These tests are not specifically designed to detect synthetic forms of THC, which could lead to health risks similar to those seen in the 2019-2020 vaping illness outbreak linked to Vitamin E acetate.
Industry Experts Weigh In
Josh Swider, CEO of Infinite Chemical Analysis, and Cassin Coleman, chair of the National Cannabis Industry Association’s scientific advisory committee, both express concerns about the safety and integrity of these synthetic products. They emphasize the need for more comprehensive testing and regulation to prevent potential health crises similar to past vaping-related illnesses.
Consumer Awareness and Safety
The situation highlights the need for greater transparency and consumer awareness regarding the sources and safety of marijuana vaping products. As the industry evolves, ensuring the health and safety of consumers remains a paramount concern, necessitating stricter testing and regulatory measures to address these emerging challenges.
